Mental disorder
- Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry (05 Sep 2022)
- Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities (01 Sep 2022)
- Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression (27 Aug 2022)
- Dos(e)Age: Role of Dose and Age in the Long-Term Effect of Cannabinoids on Cognition (05 Aug 2022)
- The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System (31 Jul 2022)
- Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders (31 Jul 2022)
- Medicinal Cannabis and Central Nervous System Disorders (31 Jul 2022)
- The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients - Journal of Cannabis Research (26 Jul 2022)
- The therapeutic role of Cannabidiol in mental health: a systematic review - Journal of Cannabis Research (26 Jul 2022)
- Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists - Journal of Cannabis Research (26 Jul 2022)
- Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series - Journal of Cannabis Research (26 Jul 2022)
- Comparison of cannabidiol to citalopram in targeting fear memory in female mice - Journal of Cannabis Research (26 Jul 2022)
- CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature - Journal of Cannabis Research (26 Jul 2022)
- Medicinal cannabis may reduce behavioral problems in kids with intellectual disabilities (18 Jul 2022)